Skip to main content
SpringerLink
Log in

Confluent and Reticulated Papillomatosis

A Review of the Literature

  • Review Article
  • Published:
American Journal of Clinical Dermatology Aims and scope Submit manuscript

Abstract

Confluent and reticulated papillomatosis (CARP) was first described >60 years ago. It is distinct from acanthosis nigricans. This article presents the results of a review of the literature in MEDLINE through May 2006 using the terms ‘confluent and reticulated papillomatosis’, ‘reticulated and confluent papillomatosis of Gougerot and Carteaud’, and ‘reticulated papillomatosis’.

A recent report has linked the presence of Dietzia spp. (family: Dietziaceae; suborder: Corynebacterineae; order: Actinomycetales) in the skin to CARP. CARP has also been linked to defects in keratinization. Other possible causes of CARP that have been suggested but seem less likely include endocrine abnormalities, Pityrosporum, a reaction to UV light, and a variation of cutaneous amyloidosis. CARP has been reported worldwide and occurs in both sexes, all age groups, and all races. The disorder can initially manifest as hyperkeratotic or verrucous papules that coalesce to form a reticular pattern peripherally and confluent plaques centrally.

Although a variety of treatments for CARP exist, oral minocycline 50–100mg twice daily has been the preferred treatment. However, recent reports of the effectiveness of azithromycin 250-500mg three times weekly may make azithromycin the preferred treatment for CARP, since it has a more benign adverse effect profile than minocycline. Other effective antibacterial treatments include fusidic acid 1000mg daily, clarithromycin 500mg daily, erythromycin 1000mg daily, tetracycline 500mg twice daily, and cefdinir 300mg twice daily. If a recent finding that CARP is caused by a bacterial microorganism is replicated, treatment should likely be determined by bacterial sensitivities, antibacterial adverse effect profiles, and cost considerations. Other oral treatments of CARP that are effective but currently disfavored because of the effectiveness of minocycline include isotretinoin, acitretin, and etretinate. There have been mixed reports regarding the effectiveness of topical treatments, which include selenium sulfide, ketoconazole cream, tretinoin, tazarotene, tacalcitol, and calcipotriene (calcipotriol).

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9

Similar content being viewed by others

References

  1. Gougerot H, Carteaud A. Papillomatose pigmentée innominée. Bull Soc Fr Dermalol Syphiligr. 1927; 34: 719

    Google Scholar 

  2. Wise F, Sachs W. Cutaneous papillomatose: papillomatose confluente et reticulée. Arch Dermatol Syphilol. 1937; 36: 475–85

    Article  Google Scholar 

  3. Wise F. Confluent and reticular papillomatosis (Gougerot-Carteaud). Arch Dermalot Syphilol. 1937; 35: 550

    Google Scholar 

  4. Decroix J, Bourlond A, Minet A, et al. Gougerot-Carteaud confluent and reticulated papillomatosis associated with pseudoacanthosis nigricans: the same entity?. Ann Dermatol Venereol. 1987; 114: 223–6

    PubMed  CAS  Google Scholar 

  5. Watkins DB, Lockwood H. Confluent and reticulated cutaneous papillomatosis; report of a case. AMA Arch Dermatol. 1957; 76: 648–51

    Article  CAS  Google Scholar 

  6. Kruger H, Winkler K. Confluent and reticular papuloid papillomatosis. Z Haut Geschlechtskr. 1967; 42: 249–52

    PubMed  CAS  Google Scholar 

  7. Palomeque FE, Hairston Jr MA. Confluent and reticulated cutaneous papillomatosis. Arch Dermatol. 1965; 92: 49–51

    Article  PubMed  CAS  Google Scholar 

  8. Watkins DB, Hoeffler DF. Confluent and reticulated cutaneous papillomatosis: report of a case and commentary. JAMA. 1960; 174: 1153–6

    Article  PubMed  CAS  Google Scholar 

  9. San P, Lupton GP. Reticulated truncal pigmentation: confluent and reticulated papillomatosis of Gougerot and Carteaud. Arch Dermatol. 1988; 124: 1272–5

    Article  Google Scholar 

  10. Friart G, Van der Meiren L. Gougerot-Carteaud’s confluent and reticulated papillomatosis. Arch Belg Dermatol Syphiligr. 1957; 13: 154–5

    PubMed  CAS  Google Scholar 

  11. Duperrat B, Gole L. A further case of Gougerot-Carteaud confluent and reticulated papillomatosis. Presse Med. 1965 Jan 27; 73: 251–4

    PubMed  CAS  Google Scholar 

  12. Bonelli M, Bubola D. Confluent and reticulated papular papillomatosis of Gougerot and Carteaud. G Ital Dermatol. 1961; 102: 255–92

    PubMed  CAS  Google Scholar 

  13. Atasoy M, Aliagaoglu C, Erdem T. A case of early onset confluent and reticulated papillomatosis with an unusual localization. J Dermatol. 2006; 33: 273–7

    Article  PubMed  Google Scholar 

  14. Natarajan S, Milne D, Jones AL, et al. Dietzia strain X: a newly described Actinomycete isolated from confluent and reticulated papillomatosis. Br J Dermatol. 2005; 153: 825

    Article  PubMed  CAS  Google Scholar 

  15. Davis MD, Weenig RH, Camilleri MJ. Confluent and reticulate papillomatosis (Gougerot-Carteaud syndrome): a minocycline-responsive dermatosis without evidence for yeast in pathogenesis: a study of 39 patients and a proposal of diagnostic criteria. Br J Dermatol. 2006; 154: 287–93

    Article  PubMed  CAS  Google Scholar 

  16. Hamilton D, Tavafoghi V, Schafer JC, et al. Confluent and reticulated papillomatosis of Gougerot and Carteaud: its relation to other papillomatoses. J Am Acad Dermatol. 1980; 2: 401–10

    PubMed  CAS  Google Scholar 

  17. Becker KA, Schwartz RA. Confluent and reticulated papillomatosis [online]. Available from URL: http://www.emedicine.com/derm/topic82.htm [Accessed 2006 Aug 30]

    Google Scholar 

  18. Beurey J, Vadot J, Mougeolle JM, et al. Confluent and reticulated papillomatosis of Gougerot and Carteaud associated with pityriasis versicolor. Bull Soc Fr Dermatol Syphiligr. 1965; 72: 416–8

    PubMed  CAS  Google Scholar 

  19. Duveme J, Volle H, Gogue Y, et al. Gougerot and Carteaud confluent and reticulated papillomatosis with the presence of pityriasis versicolor. Bull Soc Fr Dermatol Syphiligr. 1966; 73: 335–6

    Google Scholar 

  20. Yesudian P, Kamalam S, Razack A. Confluent and reticulated papillomatosis (Gougerot-Carteaud): an abnormal host reaction to MalasseZia furfur. Acta Dermatol Venereol. 1973; 53: 381–4

    CAS  Google Scholar 

  21. Gupta AK, Batra R, Bluhm R, et al. Skin diseases associated with MalasseZia species. J Am Acad Dermatol. 2004; 51: 785–98

    Article  PubMed  Google Scholar 

  22. et-Tonsy MH, el-Benhawi MO, Mehregan AH. Confluent and reticulated papillomatosis. J Am Acad Dermatol. 1987; 16: 893–4

    Article  Google Scholar 

  23. Hirokawa M, Matsumoto M, Iizuka H. Confluent and reticulated papillomatosis: a case with concurrent acanthosis nigricans associated with obesity and insulin resistance. Dermatology. 1994; 188: 148–51

    Article  PubMed  CAS  Google Scholar 

  24. Baalbaki SA, Natarajan S, Al-Khars MA. Confluent and reticulated papillomatosis: treatment with antibiotics. J Dermatol Treat. 1995; 6: 13–5

    Article  Google Scholar 

  25. Montemarano AD, Hengge M, San P, et al. Confluent and reticulated papillomatosis: response to minocycline. J Am Acad Dermatol. 1996; 34: 253–6

    Article  PubMed  CAS  Google Scholar 

  26. Vassileva S, Pramatarov K, Popova L. Ultraviolet light-induced confluent and reticulated papillomatosis. J Am Acad Dermatol. 1989; 21: 413–4

    Article  PubMed  CAS  Google Scholar 

  27. Groh V, Schnyder UW. Nosology of confluent and reticulated papillomatosis (Gougerot-Carteaud). Hautarzt. 1983; 34: 81–6

    PubMed  CAS  Google Scholar 

  28. Henning JP, de Wit RF. Familial occurrence of confluent and reticulated papillomatosis. Arch Dermatol. 1981; 117: 809–10

    Article  PubMed  CAS  Google Scholar 

  29. Stein JA, Shin HT, Chang MW. Confluent and reticulated papillomatosis associated with tinea versicolor in three siblings. Pediatr Dermatol. 2005; 22: 331–3

    Article  PubMed  Google Scholar 

  30. Schwartzberg JB, Schwartzberg HA. Response of confluent and reticulate papillomatosis of Gougerot and Carteaud to topical tretinoin. Cutis. 2000; 66: 291–3

    PubMed  CAS  Google Scholar 

  31. Kagi MK, Trueb R, Wuthrich B, et al. Confluent and reticulated papillomatosis associated with atopy: successful treatment with topical urea and tretinoin. Br J Dermatol. 1996; 134: 381–2

    Article  PubMed  CAS  Google Scholar 

  32. Kumar AS, Pandhi RK. Syndrome of Carteaud and Gougerot: case report. Confluent and reticulate papillomatosis. Mykosen. 1984; 27: 313–5

    Article  PubMed  CAS  Google Scholar 

  33. Thomsen K. Confluent and reticulated papillomatosis (Gougerot-Carteaud). Acta Derm Venereol Suppl (Stockh). 1979; 59: 185–7

    CAS  Google Scholar 

  34. Basak PY, Baysal V, Ozcanli C. Confluent and reticulated papillomatosis: failure of response to calcipotriol and coincidental association with vascular mottling. J Fur Acad Dermatol Venereol. 2001; 15: 591–2

    Article  CAS  Google Scholar 

  35. Nagy R, Fairfield JC. Confluent and reticulated papillomatosis. Cutis. 1982; 29: 48–50

    PubMed  CAS  Google Scholar 

  36. Barnette Jr DJ, Yeager JK. A progressive asymptomatic hyperpigmented papular eruption: confluent and reticulated papillomatosis (CRP) of Gougerot and Carteaud. Arch Dermatol. 1993; 129: 1608–9, 1611–2

    Article  PubMed  Google Scholar 

  37. Hallel-Halevy D, Grunwald MH, Halevy S. Confluent and reticulated papillomatosis (Gougerot-Carteaud) of the pubic region [letter]. Acta Dermatol Venereol. 1993; 73:155

    CAS  Google Scholar 

  38. Palomeque FE, Hairston Jr MA. Confluent and reticulated papillomatosis of Gougerot and Carteaud. Arch Dermatol. 1965; 92: 49–51

    Article  PubMed  CAS  Google Scholar 

  39. Abbud Neto S, di Stasi LL, Pires MC, et al. Pseudo-atrophoderma colli and Gougerot-Carteaud confluent reticulated papillomatosis (shining atrophy). Med Cutan Ibero Lat Am. 1987; 15: 477–80

    PubMed  CAS  Google Scholar 

  40. Lee MW, Goldberg LH, Dorsey K, et al. Syringoma resembling confluent and reticulated papillomatosis of Gougerot-Carteaud. Cutis. 1998; 61: 227–8

    PubMed  CAS  Google Scholar 

  41. Schnur RE, Heymann WR. Reticulate hyperpigmentation. Semin Cutan Med Surg. 1997; 16: 72–80

    Article  PubMed  CAS  Google Scholar 

  42. Griffiths CE. Gougerot-Carteaud still an enigma after all these years. J Dermatolog Treat. 2002; 13 (1): 27–30

    Article  Google Scholar 

  43. Weedon D. Skin pathology: miscellaneous conditions. London: Churchill Livingstone, 2002

    Google Scholar 

  44. Mutasim DF. Confluent and reticulated papillomatosis without papillomatosis. J Am Acad Dermatol. 2003; 49: 1182–4

    Article  PubMed  Google Scholar 

  45. Diez E, Alonso LM, Zambrano B, et al. Confluent and reticulated papillomatosis without papillomatosis [letter]. J Am Acad Dermatol. 2005; 52: E8

    Article  PubMed  Google Scholar 

  46. Lee SH, Choi EH, Lee WS, et al. Confluent and reticulated papillomatosis: a clinical histopathological and electron microscopic study. J Dermatol. 1991; 18: 725–30

    PubMed  CAS  Google Scholar 

  47. Jimbow M, Talpash O, Jimbow K. Confluent and reticulated papillomatosis: clinical light and electron microscopic studies. Int J Dermatol. 1992; 31: 480–3

    Article  PubMed  CAS  Google Scholar 

  48. Kanitakis J, Zambruno G, Viac J, et al. Involucrin expression in keratinization disorders of the skin: a preliminary study. Br J Dermatol. 1987; 117: 479–86

    Article  PubMed  CAS  Google Scholar 

  49. Carteaud A. A case of Gougerot and Carteaud’s confluent and reticulated papulous papillomatosis, completely cleared up by antibiotics. Bull Soc Fr Dermatol Syphiligr. 1965; 72: 396–7

    PubMed  CAS  Google Scholar 

  50. Chang SN, Kim SC, Lee SH, et al. Minocycline treatment for confluent and reticulated papillomatosis. Cutis. 1996; 57: 454–7

    PubMed  CAS  Google Scholar 

  51. Shimizu S, Han-Yaku H. Confluent and reticulated papillomatosis responsive to minocycline. Dermatology. 1997; 194: 59–61

    Article  PubMed  CAS  Google Scholar 

  52. Sassolas B, Plantin P, Guillet G. Confluent and reticulated papillomatosis: treatment with minocycline. J Am Acad Dermatol. 1992; 26: 501–2

    Article  PubMed  CAS  Google Scholar 

  53. Petit A, Evenou P, Civatte J. Confluent and reticulated papillomatosis of Gougerot and Carteaud: treatment by minocycline. Ann Dermatol Venereol. 1989; 116: 29–30

    PubMed  CAS  Google Scholar 

  54. Puig L, de Moragas JM. Confluent and reticulated papillomatosis of Gougerot and Carteaud: minocycline deserves trial before etretinate. Arch Dermatol. 1995; 131: 109–10

    Article  PubMed  CAS  Google Scholar 

  55. Wiesenborn A, Hengge U, Megahed M. Confluent and reticulated papillomatosis: Gougerot-Carteaud disease. Hautarzt. 2004; 55: 976–8

    PubMed  CAS  Google Scholar 

  56. Jang HS, Oh CK, Cha JH, et al. Six cases of confluent and reticulated papillomatosis alleviated by various antibiotics. J Am Acad Dermatol. 2001; 44: 652–5

    Article  PubMed  CAS  Google Scholar 

  57. Atasoy M, Ozdemir S, Aktas A, et al. Treatment of confluent and reticulated papillomatosis with azithromycin. J Dermatol. 2004; 31: 682–6

    PubMed  Google Scholar 

  58. Ito S, Hatamochi A, Yamazaki S. A case of confluent and reticulated papillomatosis that successfully responded to roxithromycin. J Dermatol. 2006; 33: 71–2

    Article  PubMed  Google Scholar 

  59. Michel PJ, Cretin J. A case of reticulated confluent Gougerot-and Carteaud papillomatosis cured by the treatment proposed by Carteaud (furacycline). Bull Soc Fr Dermatol Syphiligr. 1969; 76: 112–3

    PubMed  CAS  Google Scholar 

  60. Angeli-Besson C, Koeppel MC, Jacquet P, et al. Confluent and reticulated papillomatosis (Gougerot-Carteaud) treated with tetracyclines. Int J Dermatol. 1995; 34: 567–9

    Article  PubMed  CAS  Google Scholar 

  61. Yamamoto A, Okubo Y, Oshima H, et al. Two cases of confluent and reticulate papillomatosis: successful treatments of one case with cefdinir and another with minocycline. J Dermatol. 2000; 27: 598–603

    PubMed  CAS  Google Scholar 

  62. Nordby CA, Mitchell AJ. Confluent and reticulated papillomatosis responsive to selenium sulfide. Int J Dermatol. 1986; 25: 194–9

    Article  PubMed  CAS  Google Scholar 

  63. Friedman SJ, Albert HL. Confluent and reticulated papillomatosis of Gougerot and Carteaud: treatment with selenium sulfide lotion. J Am Acad Dermatol. 1986; 14: 280–2

    Article  PubMed  CAS  Google Scholar 

  64. Hamaguchi T, Nagase M, Higuchi R, et al. A case of confluent and reticulated papillomatosis responsive to ketoconazole cream. Nippon Ishinkin Gakkai Zasshi. 2002; 43: 95–8

    Article  Google Scholar 

  65. Lee MP, Stiller MJ, McClain SA, et al. Confluent and reticulated papillomatosis: response to high-dose oral isotretinoin therapy and reassessment of epidemiclogic data. J Am Acad Dermatol. 1994; 31: 327–31

    Article  PubMed  Google Scholar 

  66. Hodge JA, Ray MC. Confluent and reticulated papillomatosis: response to isotretinoin [letter]. J Am Acad Dermatol. 1991; 24: 654

    Article  PubMed  CAS  Google Scholar 

  67. Solomon BA, Laude TA. Two patients with confluent and reticulated papillomatosis: response to oral isotretinoin and 10% lactic acid lotion. J Am Acad Dermatol. 1996; 35: 645–6

    Article  PubMed  CAS  Google Scholar 

  68. Bruynzeel-Koomen CA, de Wit RF. Confluent and reticulated papillomatosis successfully treated with the aromatic etretinate. Arch Dermatol. 1984; 120: 1236–7

    Article  PubMed  CAS  Google Scholar 

  69. Baalbaki SA, Malak JA, al-Khars MA. Confluent and reticulated papillomatosis: treatment with etretinate. Arch Dermatol. 1993; 129: 961–3

    Article  PubMed  CAS  Google Scholar 

  70. Bowman PH, Davis LS. Confluent and reticulated papillomatosis: response to tazarotene. J Am Acad Dermatol. 2003; 48: S80–1

    Article  PubMed  Google Scholar 

  71. Carrozzo AM, Gatti S, Ferranti G, et al. Calcipotriol treatment of confluent and reticulated papillomatosis (Gougerot-Carteaud syndrome). J Fur Acad Dermalot Venereol. 2000; 14: 131–3

    Article  CAS  Google Scholar 

  72. Gulec AT, Seckin D. Confluent and reticulated papillomatosis: treatment with topical calcipotriol. Br J Dermatol. 1999; 141: 1150–1

    Article  PubMed  CAS  Google Scholar 

  73. Kurkcuoglu N, Celebi CR. Confluent and reticulated papillomatosis: response to topical calcipotriol. Dermatology. 1995; 191: 341–2

    Article  PubMed  CAS  Google Scholar 

  74. Yamamoto Y, Kadota M, Nishimura Y. A case of maxacalcitol-resistant confluent and reticulated papillomatosis successfully treated with minocycline. J Dermalot. 2006; 33: 223–4

    Google Scholar 

  75. Ginarte M, Fabeiro JM, Toribio J. Confluent and reticulated papillomatosis (Gougerot-Carteaud) successfully treated with tacalcitol. J Dermatolog Treat. 2002; 13: 27–30

    Article  PubMed  CAS  Google Scholar 

  76. Rollier E. Confluent reticulated papillomatosis of Gougerot and Carteaud. Arch Belg Dermatol Syphiligr. 1958; 14: 99–101

    PubMed  CAS  Google Scholar 

  77. Fontaine A, Wellens W. A case of Gougerot and Carteaud’s confluent and reticulated papillomatosis. Arch Belg Dermatol Syphiligr. 1958; 14: 232–6

    PubMed  CAS  Google Scholar 

  78. Young AW. Cutaneous papillomatosis; confluent and reticulated variety. AMA Arch Dermatol Syphilol. 1953; 67: 594–7

    Article  CAS  Google Scholar 

  79. Gruber F, Zamolo G, Saftic M, et al. Treatment of confluent and reticulated papillomatosis with azithromycin [letter]. Clin Exp Dermatol. 1998; 23: 191

    Article  PubMed  CAS  Google Scholar 

  80. Ekmekci TR, Altunay IK, Koslu A. Prurigo pigmentosa treated with doxycycline. Dermatol Online J. 2006; 12 (1): 9

    PubMed  Google Scholar 

  81. Cannavo SP, Guarneri C, Borgia F, et al. Confluent and reticulated papillomatosis and acanthosis nigricans in an obese girl: two distinct pathologies with a common pathogenetic pathway or a unique entity dependent on insulin resistance?. J Fur Acad Dermatol Venereol. 2006; 20: 478–80

    Article  CAS  Google Scholar 

Download references

Acknowledgments

No sources of funding were used to assist in the preparation of this manuscript. The author has no potential conflicts of interest that are directly relevant to the contents of this manuscript.

Author information

Authors and Affiliations

  1. Department of Dermatology, St Luke‘s-Roosevelt Hospital, 1090 Amsterdam Avenue, New York, New York, 10025, USA

    Noah Scheinfeld

Authors
  1. Noah Scheinfeld
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Noah Scheinfeld.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Scheinfeld, N. Confluent and Reticulated Papillomatosis. Am J Clin Dermatol 7, 305–313 (2006). https://doi.org/10.2165/00128071-200607050-00004

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128071-200607050-00004

Keywords

Search

Navigation